C Pradier to Risk Assessment
This is a "connection" page, showing publications C Pradier has written about Risk Assessment.
Connection Strength
0.072
-
Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int. 2018 02; 29(2):467-478.
Score: 0.032
-
Review of the guideline of the American College of Physicians on the treatment of osteoporosis. Osteoporos Int. 2018 Jul; 29(7):1505-1510.
Score: 0.017
-
Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes. J Thromb Haemost. 2018 03; 16(3):500-507.
Score: 0.008
-
Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization. Curr Vasc Pharmacol. 2018; 16(4):405-413.
Score: 0.008
-
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med. 2018 02; 19(2):102-117.
Score: 0.008